Can-Fite BioPharma Ltd.

AMEX: CANF · Real-Time Price · USD
0.66
-0.01 (-1.79%)
At close: Aug 15, 2025, 3:59 PM
0.67
0.65%
After-hours: Aug 15, 2025, 06:14 PM EDT

Can-Fite BioPharma Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
674K 743K 810K 853K
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
674K 743K 810K 853K
Operating Income
-8.13M -8.2M -10.1M -12.84M
Interest Income
291K 506K 222K 24K
Pretax Income
-7.88M -7.63M -10.17M -12.62M
Net Income
-7.88M -7.63M -10.53M -12.6M
Selling & General & Admin
3.05M 2.96M 3.14M 3.85M
Research & Development
5.76M 5.98M 7.76M 9.85M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
8.8M 8.94M 10.91M 13.7M
Interest Expense
14K 14K 16K 18K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
8.8M 8.94M 10.91M 13.7M
Income Tax Expense
n/a n/a 360K -20K
Shares Outstanding (Basic)
7.25M 4.26M 2.72M 1.53M
Shares Outstanding (Diluted)
7.25M 4.26M 2.72M 1.84M
EPS (Basic)
-1.08 -1.8 -3.75 -8.25
EPS (Diluted)
-1.08 -1.8 -3.75 -8.25
EBITDA
-8.12M -8.18M -10.08M -12.83M
EBIT
-8.13M -8.2M -10.1M -12.84M
Depreciation & Amortization
7K 15K 14K 14K